INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 15, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Open market or private sale of non-derivative or derivative security | 406 | $971.28 | 877,493 |
| May 15, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Open market or private sale of non-derivative or derivative security | 846 | $970.36 | 877,899 |
| May 15, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Open market or private sale of non-derivative or derivative security | 1,930 | $969.14 | 878,745 |
| May 15, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Open market or private sale of non-derivative or derivative security | 3,387 | $968.43 | 880,675 |
| Dec 30, 2020 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 240,000 | $52.03 | 880,938 |
| May 15, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Open market or private sale of non-derivative or derivative security | 1,428 | $967.45 | 884,062 |
| May 15, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Open market or private sale of non-derivative or derivative security | 782 | $966.29 | 885,490 |
| May 15, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Open market or private sale of non-derivative or derivative security | 111 | $965.69 | 886,272 |
| May 01, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 673
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 886,383 |
| Aug 16, 2021 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 2,302 | $626.10 | 887,483 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.